March 26, 2025

A University of Maryland School of Medicine study has revealed that data from pre-treatment CT scans can serve as imaging biomarkers to predict patient prognosis in head and neck squamous cell carcinoma. This approach may enable oncologists to customize treatment strategies, potentially reducing the risk of permanent side effects such as impairments in vision, swallowing, or speech. By tailoring therapies based on these biomarkers, patient outcomes could be significantly improved.

Explore how this innovative CT scan technique is poised to revolutionize head and neck cancer care and enhance patients’ quality of life.